Target intelligence / Profile preview

Eukaryotic translation initiation factor 4E pseudogene 3 (EIF4EP3)

Target: EIF4EP3
Molecular classification: Other

Overview

EIF4EP3 (eukaryotic translation initiation factor 4E pseudogene 3) is identified as a pseudogene in the human genome and does not encode a functional protein product. Pseudogenes are DNA sequences similar to normal genes but are generally nonfunctional, lacking the ability to be transcribed into a functional protein, and are not considered therapeutic drug targets. There is no evidence of EIF4EP3 being involved in biological pathways, disease mechanisms, or drug interactions. Its name derives from sequence similarity to eukaryotic translation initiation factor 4E (EIF4E), but it is not a receptor, enzyme, transporter, or other classical drug target category.

Other names: EIF4E pseudogene 3eIF4EP3

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 4E pseudogene 3 (EIF4EP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 4E pseudogene 3 (EIF4EP3).

Explore the full profile